J2KBIO Co., Ltd. (KOSDAQ:420570)
8,660.00
+820.00 (10.46%)
At close: Jul 21, 2026
-21.49% (1Y)
| Market Cap | 50.64B -21.5% |
| Revenue (ttm) | 36.82B +13.0% |
| Net Income | 4.03B +39.4% |
| EPS | 690.98 +36.0% |
| Shares Out | 5.85M |
| PE Ratio | 12.53 |
| Forward PE | n/a |
| Dividend | 250.00 (3.19%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 55,237 |
| Open | 7,500.00 |
| Previous Close | 7,840.00 |
| Day's Range | 7,500.00 - 8,770.00 |
| 52-Week Range | 6,710.00 - 11,850.00 |
| Beta | 0.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |